Editorial Board
Chi Leung CHIANG
Department of Clinical Oncology, University of Hong Kong · Hong Kong
Editorial leadership for Journal of Neoplasms ISSN 2639-1716
Research interests
- Stereotactic Body Radiotherapy Gastrointestinal Brachytherapy Circulating Tumor Cells Colorectal Cancer Hepato-Biliary-Pancreatic Cancer
Biography
- Dr. Chiang Chi-leung graduated from The Chinese University of Hong Kong in 2004 and completed his specialist training at the Department of Clinical Oncology in Tuen Mun Hospital.
- He joined the Department of Clinical Oncology, LKS Faculty of Medicine HKU since January 2017.
- He has received overseas training in stereotactic radiation for hepato-biliary-pancreatic cancer at John Hopkins Hospital (USA) and Princess Margaret Hospital (Canada) in 2013.
- Later in 2015, he has pursued subspecialty training on the application of brachytherapy in gastrointestinal cancer in Jewish General Hospital (Canada). Besides, he obtained the Postgraduate Diploma in Epidemiology and Biostatistics (CUHK) in 2012.
- Dr. Chiang is actively involved in the teacing of medical students and nurses.
- His main resarch and clinical interests include pancreatic cancer, colorectal cancer, and liver malignancy. He published peer review journal and presented at various local and international conferences.
Selected publications
- Prognostic Biomarkers for Survival in Nasopharyngeal Carcinoma: A Systematic Review of the Literature 2022 cited 21×
- Association of Multi-Phasic MR-Based Radiomic and Dosimetric Features with Treatment Response in Unresectable Hepatocellular Carcinoma Patients following Novel Sequential TACE-SBRT-Immunotherapy 2023 cited 17×
- Dosimetric benefits of 3D-printed modulated electron bolus following lumpectomy and whole-breast radiotherapy for left breast cancer 2023 cited 11×
- Efficacy, safety, and correlative biomarkers of bintrafusp alfa in recurrent or metastatic nasopharyngeal cancer patients: a phase II clinical trial 2023 cited 8×
- External Validation of a Nomogram to Predict Survival and Benefit of Concurrent Chemoradiation for Stage II Nasopharyngeal Carcinoma 2021 cited 6×
- Development and usability testing of a technology-based intervention for promoting physical activity among post-treatment cancer survivors (WExercise) using the multi-process action control framework 2024 cited 3×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JN for your work?
This journal is guided by Chi Leung CHIANG (Department of Clinical Oncology, University of Hong Kong) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.